propecia generic date 2012

Propecia, a drug used to treat male pattern baldness, has been available in the market since 1997. The original brand name for the drug is Proscar, which is manufactured by Merck & Co., Inc. The patent on Proscar expired in April 2012 and since then, generic versions of the drug have been available in the market. The Food and Drug Administration (FDA) approved the first generic version of Propecia in December 2012. This version of the drug is manufactured by Teva Pharmaceuticals and is available in 5mg and 1mg strengths. Other companies, such as Mylan and Watson Pharmaceuticals, also received approval to produce generic versions of Propecia, which were launched in the market later that year. The availability of generic versions of Propecia has been a great relief for many men who suffer from male pattern baldness. Generic drugs are typically less expensive than brandname drugs, making it more accessible to people who need it. The FDA ensures that all generics approved for sale in the US meet the same quality standards as the brandname drugs they copy. It's important to note that while generic versions of Propecia are available, they may not be identical to the original drug. It is always recommended to consult with a healthcare professional before starting any new medication, including generics. They can help determine if the generic version of Propecia is right for you and monitor your response to the treatment. In conclusion, the expiration of the patent on Proscar in 2012 allowed generic versions of Propecia to enter the market, making it more accessible to men who suffer from male pattern baldness. The FDA ensures that all generics approved for sale in the US meet the same quality standards as the brandname drugs they copy. Always consult with a healthcare professional before starting any new medication, including generics.